Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbb-2 (her-2/neu) gene product p185

This publication has 17 references indexed in Scilit:

• A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines
  International Journal of Cancer, 1992
• Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells
  Cell, 1992
• Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.
  Proceedings of the National Academy of Sciences, 1992
• Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 ^{erb B2}
  Science, 1990
• p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.
  Molecular and Cellular Biology, 1989
• Analysis of radioligand binding experiments
  Journal of Pharmacological Methods, 1985
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985
• A practical computer-based approach to the analysis of radioligand binding experiments
  Computer Programs in Biomedicine, 1983
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
  Biochemical and Biophysical Research Communications, 1978
• New Human Tumor Cell Lines
  Published by Springer Nature ,1975